DEFINITION/INTRODUCTION
Liver
metastases is malignancy of the hepatic cells following a spreads from other malignant organs or tissues
and this is more often than not due to its size, increase rate of
blood flow, double perfusion by both the
hepatic artery and portal vein. Also due to the Kupffer cell filtration ability
combine to make it is much more common than primary liver cancers.
This feature of being a major site of
metastatic growth is second only to lymph nodes in the body. Except for malignant tumors primarily in
the brain any other cancer may spread to the liver but the most common source
tumor that produce a liver metastases include the colon,
breast, lung, pancreas as
well as melanomas are very common. Less commonly cancers could spread are from the
thyroid, prostate, and skin.
The
symptoms as at the time of presentation will reflect more of the primary cancer
and metastases to the liver is usually discovered during investigations, though
liver involvement may be shown by constitutional symptoms some of which are
reduced appetite,fever, weight loss and sweating. patients with advanced
hepatic involvement shows features suggestive of malignancy and hepatic enlargement.
Others maybe abdominal pain and jaundice.
The risk factors mainly due to the size of the tumor, blood supply and position
of the primary tumor furthermore spaces in the endothelial wall of liver blood vessels
allow cancer cells to reach the functional hepatic cells.
INVESTIGATIONS
Some form of clinical
assessment will give a clue of liver involvement before the major investigation
and every patient with any form of primary malignancy should be fully screened
for metastases to various sites including the liver,except for brain tumors
that are not expected to metastasis to the liver,common investigation showing a raised level of
alkaline phosphatase or a mass apparent on ultrasound, CT, or MRI examination
of the liver may provide a presumptive diagnosis,more reliable diagnosis is got
from biopsy taken under ultrasound,CT guided or during laparoscopic procedure.
Commonly, multiple nodular metastases are found that often cause striking
hepatomegaly and may replace over 80% of existent hepatic parenchyma.in some
cases the primary tumor may give a rise to some enzymes in the liver for
example carcinoembyronic antigen is released by the primary tumor into the serum
in about 70% of patients with colorectal cancer, there is usually a fall in serum
levels after primary tumor removal.other investigations include PET scan,liver
function test,full blood count,serum bilurbin.
MANAGEMENT
Management of metastatic liver
malignancy is multi-factorial based, including the primary site of the tumor ,
the percentage of tumor in the liver parenchyma , the presence of other site of
metastasis (such as, to the spleen), and any other coexisting health condition.
A combination of all the above factors are of huge importance when the management plans is considered
.
Surgical: Surgical management with the goal of
curing the malignancy is an option in some type of tumors. If the site of
metastasis is the part of the liver without any form metastasis to any other
organ in the body then technically a cure can be achieved when the part of the
liver containing the metastatic cells is removed. On a general note , patients who
had the whole tumor removed have the best chance of surviving. In most cases
when surgery is the treatment plan, it is done in with chemotherapy as an
adjunct. Examples of lesions where surgical treatment could be considered include:
large intestine and rectum, anus, neuroendocrine, breast and lungs . Surgical
options include: Partial liver resection (the portion of the liver with
metastatic cells is removed) or hemi-hepatectomy (one half of the liver is
resected).
Microwave
ablation: In this treatment modality heat therapy is applied to destroy the
metastatic cells. The treatment is done under ultrasound guidance with a
special probe inserted. The probe then “heats up” the tumor to kill it. Not all
tumors responds to this treatment and sometimes, microwave might be used in combination
with liver resection. Radiofrequency
ablation is a heat therapy, with some similarity to microwave.
Chemotherapy :Patients with metastatic
malignancy of the liver can have their lives prolonged by chemotherapy
especially in patients that cannot with stand surgery, although chemotherapy
may not be curative cure on its own. Chemotherapy is a treatment option that uses anti-neoplastic medications
to destroy malignant cells, or to stop their multiplication. though it is not
likely to bring about a cure, but may reduce size of the tumor down to slow the growth rate of the
malignancy. Chemotherapy is more efficient when used in combination with other
treatment modalities for example:Surgical. Chemotherapy is mainly given systemically
through the vein of either the arm or, more oftenly, through a
specially-implanted port in the chest. Metastatic pancreatic tumor to the liver
is an example of cancer that would be typically managed with systemic
chemotherapy. Another means of administering chemotherapeutic agents is Chemoembolisation.
In this treatment modality, medications
utilized in chemotherapy is given directly into branches of the hepatic vessel which
supply the tumor and it is
combined with a substance that blocks the blood vessel and obstruct the blood supply and
to starve the tumor of nourishment. This form of treatment might be utilized in
cases of neuroendocrine or renal malignancies
. Not all metastatic cancers are responsive to this type of treatment. Furthermore
hepatic arterial infusion is another
management plan with some similarities with chemoembolisation but no special
substance is given to deprive the cells
of blood supply and a commonly used drug
is floxuridine(FUDR).
Radiation
therapy: This is a treatment which utilizes high energy beams of radiation
which are focused on cancerous tissue. This kills cancer cells, or stops cancer
cells from multiplying. This is currently not a commonly used treatment option
for metastatic liver malignancy, and not all malignant cell types or tumors are
amenable to this treatment option.
Radioembolisation:This
is a newer form of treatment where radiation is attached to small beads called microspheres which are then injected
into the blood vessels supplying the liver malignancy.
Stereotactic
body radiation therapy:this is a type of external beam that deliver high dose
of radiation directly to a tumor when there are 1-3 small liver metastases .It
avoids radiation to normal tissues.
Liver transplant
This
normally available to only a small number of patients with liver metastasis are
candidates for a liver transplant because of the strict criteria they have to
meet.
COMPLICATIONS
Complications are mainly due to
tumor occupying a large proportion of the liver .they include:
Obstruction of bile flow
Reduced appetite
Liver failure
Pains
Weight loss
CAN YOU LIVE WITH
LIVER CANCER?
Liver cancer is a chronic disease that is debilitating
and requires long term management
especially with the high rate of reoccurrence making it is a difficult
condition to live with.
SURVIVAL
RATE
Survival rates
are estimates, the outcome varies depending on
various factors peculiar
to each patient.
Localized
tumors: In this stage the
cancer is still restricted to the hepatic parenchyma, and this includes stages
I, II, and some stage III cancers. This includes different type of liver
cancers, some might be easier to manage
than others. The 5-year survival rate for people with localized liver cancer
is around 30.5%.though some patients may survive longer than that.
Regional
liver cancers :This means the cancer has
spread into nearby organs like the spleen or has spread to nearby lymph nodes,
and includes stages IIIC and IVA cancers. For regional stage liver cancer,
the 5-year survival rate is about 10.7%.
Distant
metastatic liver: This means
that the cancer has spread to distant organs or tissues and is this is
equivalent to stage IVB. The 5-year relative survival rate for distant stage
liver cancer is about 3.1%.
In
general, survival rates are higher for people who can have surgery to remove
their cancer,
regardless
of the stage. For example, studies have shown that patients with small,
resectable
tumors
who do not have cirrhosis or other serious health problems are likely to do
well if their
cancers
are removed. Their overall 5-year survival is over 50%. For people with
early-stage liver
cancers
who have a liver transplant, the 5-year survival rate is in the range of 60% to
70%.
PREVENTION
Prevention of liver
cancer can be mainly be by lifestyle modifications which will minimize risk
factors for cancer.
Reduce consumption of
alcohol
Prevent risk factors
for hepatitis B and C e.g sharing sharps
Early management of
other cancers to prevent metastases to the liver
Vaccination against
hepatitis B
Avoid unprotected sex
Avoid exposure to
arsenic
Transfusion of only
properly screened blood.
Limiting liver
metabolized drugs
Eating healthy diet
rich in fresh vegetable and grains
PROGNOSIS
Prognosis is generally
very poor but with better chances in
patients with surgically amenable tumors and without spread to other organs and
tissues.
No comments:
Post a Comment